USD 48.37 billion
Gastroenterology Market Size, Share, Growth Analysis, By Drug Type(Antacids, Laxatives, Antidiarrheal agents, Antiemetics), By Dosage Form(Oral, Parenteral, Other Dosage Forms), By Application(Ulcerative Colitis, Irritable Bowel Syndrome, Crohn's Disease, Celiac Disease), By Region - Industry Forecast 2024-2031
Report ID:
SQSG35I2028 |
Region:
Global |
Published Date: July, 2036
Pages:
165
|Tables:
96
|Figures:
76
Gastroenterology Market Insights
Global Gastroenterology Market size was valued at USD 32.58 billion in 2022 and is poised to grow from USD 34.53 billion in 2023 to USD 55.04 billion by 2031, growing at a CAGR of 6% in the forecast period (2024-2031).
The market for gastroenterology is expanding primarily due to the rising prevalence of gastrointestinal diseases. Other significant reasons driving the growth of the gastroenterology market are the rising incidence of gastrointestinal disorders brought on by poor dietary practices, the expansion of clinical studies with reliable findings, rising healthcare costs, and the rise in the elderly population.
There is a large variety of new generation treatments that are available, including cellular therapy and inventive small compounds. Hospitalizations and surgical procedures for GI disorders are on the rise, and biopharmaceutical companies are investing more in R&D to create biologics and biosimilars. According to the National Clinical Trials (NCT) registry, there were around 6,443 ongoing clinical trials for gastrointestinal illnesses at various stages of development as of May 2021. Over the projection period, new chances for efficient medicines may be created by the successful findings of these investigations.
US Gastroenterology Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Ulcerative Colitis
Fastest Growth
Ulcerative Colitis
Growth Rate
6.21% CAGR
Global Gastroenterology Market 2022-2028 ($ Bn)
Country Share for North America Region- 2021 (%)
To get more reports on the above market click here to Buy The Report
Gastroenterology Market Segmental Analysis
The Global Gastroenterology Market is segmented based on drug type, dosage form, application, and region. Based on Drug Type, it is categorized into Antacids, Laxatives, Antidiarrheal agents, Antiemetics, Antiulcer agents, and Other Drug Types. Based on Dosage Form, it is categorized into Oral, Parenteral, and Other Dosage Forms. Based on Application, it is categorized into Ulcerative Colitis, Irritable Bowel Syndrome, Crohn's Disease, Celiac Disease, Gastroenteritis, and Other Applications. Based on region, Gastroenterology Market is categorized into North America, Europe, Asia Pacific, The Middle East and Africa, and Latin America.
Gastroenterology Market Analysis by Application
On the basis of application, the ulcerative colitis segment is expected to lead the global gastroenterology market over the forecast period.The easy availability of medications to treat ulcerative colitis on the market can be attributed to the segment's expansion. The strong clinical urgency to stop the spread of ulcerative colitis is another factor contributing to the segment's expected rapid growth. Due to the poor prognosis and use of harmful foods, there is a great likelihood that the condition will return.
Global Gastroenterology Market By Application, 2021 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Gastroenterology Market Regional Insights
Based on the region, the North American region currently dominates the global gastroenterology market. The market in North America had the biggest share in 2021 and is anticipated to hold that position during the projected period. Technological advancements, an unprecedented change in lifestyle leading to a higher incidence of gastrointestinal diseases, an increase in the number of geriatric and obese people, and rising research and development activities with the presence of key market players are some of the factors that are fueling the market growth in the North American region. Additionally, the government's measures to prevent and treat gastrointestinal disorders are anticipated to propel the market. For instance, UNICEF and WHO's Integrated Global Action Plan for Diarrhea aims to reduce the number of child deaths that can be prevented due to diarrhea by providing interventions and services to increase awareness and offer access to treatment and preventative measures.
Asia Pacific is expected to increase at an exponential rate over the projection period. Consistent efforts made by important stakeholders, including expenditures in R&D and the launch of branded medications at a relatively lower cost, are anticipated to fuel this. Additionally, it is anticipated that over the course of the projection period, the regional market would provide high potential growth possibilities due to the urgent need to reduce the high incidence rate of gastrointestinal illnesses and technological upgrades to the healthcare infrastructure.
Global Gastroenterology Market By Geography, 2022-2028
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Gastroenterology Market Dynamics
Gastroenterology Market Drivers
- Rising incidence of gastrointestinal diseases: Globally, the prevalence of gastrointestinal conditions such gallstones, ulcerative colitis, fissure, hemorrhoids, irritable bowel syndrome (IBS), and gastroesophageal reflux disease (GERD) has dramatically grown. The main causes of the rising prevalence of chronic and acute gastrointestinal illnesses are poor diet, a sedentary lifestyle, stress, food sensitivity, and bacterial or viral infections. Numerous drugs, such as antacids, histamine H2-receptor antagonists, laxatives, proton pump inhibitors, and antibiotics, are increasingly in demand to treat various gastrointestinal disorders and prevent subsequent medical consequences related to the diseases. This is driving up the demand for different classes or types of pharmaceuticals to treat gastrointestinal ailments, which is driving up the growth of the global market for therapeutics for gastrointestinal diseases.
Gastroenterology Market Restraints
- During the forecast period, the market for gastroenterology is projected to face significant obstacles due to the high cost of treatments. Different gastrointestinal illnesses are treated with biologics and small compounds. Chronic IBS include conditions like Crohn's disease and ulcerative colitis, which need ongoing care to reduce the risk of recurrence and cancer development. The cost of medications, doctor visits, and hospital stays make up the majority of the total cost of therapy for gastrointestinal illnesses. Numerous chronic gastrointestinal illnesses are treated with the intravenous administration of biologic medications like infliximab and vedolizumab. Infliximab (Remicade, Johnson & Johnson) often costs between $6,000 and $6,500, while vedolizumab (Entyvio, Takeda Pharmaceutical) typically costs between $8,500 and $8,700 per prescription. Biologics used to treat IBD often cost between $2,500 and $5,500 per month on average. The expansion of the global market for gastroenterology is predicted to be somewhat constrained by rising out-of-pocket costs related to medications and procedures for gastrointestinal diseases.
Request Free Customization of this report to help us to meet your business objectives.
Gastroenterology Market Competitive Landscape
The market for gastrointestinal medicines is moderately fragmented. To increase their market share, the market players have widely used competition sustainability methods such as new product development and regional and distribution channel expansion. Furthermore, a greater emphasis on supply chain management and operational improvement has made it easier for major companies to keep a competitive edge.
Gastroenterology Market Top Players Company Profiles
- AbbVie Inc.
- Allergan plc
- AstraZeneca plc
- Boehringer Ingelheim International GmbH
- Eisai Co., Ltd.
- GlaxoSmithKline plc
- Johnson & Johnson
- Novartis International AG
- Pfizer Inc.
- Procter & Gamble Co.
- Salix Pharmaceuticals, Inc.
- Sanofi S.A.
- Shire plc
- Takeda Pharmaceutical Company Limited
- Valeant Pharmaceuticals International, Inc.
- Amgen Inc.
- Aptalis Pharma US, Inc.
- Danone S.A.
- Ferring Pharmaceuticals
- Nestle Health Science
Gastroenterology Market Recent Developments
- In July 2022, AbbVie announced that they received the approval of RINVOQ® (upadacitinib, 45 mg [induction dosage] and 15 mg and 30 mg [maintenance doses]) from the European Commission (EC), for the treatment of adult patients with moderately to highly active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic drug.
Gastroenterology Key Market Trends
- The demand for developing cutting-edge medicines is being driven by the increase in severe to moderate gastrointestinal disorders, such as ulcerative colitis, Crohn's disease, and other gastrointestinal ailments. In order to expand their product pipeline, pharmaceutical and biotechnology businesses are concentrating on R&D to find and create novel medications for the treatment of gastrointestinal illnesses. The global market for gastrointestinal illnesses therapeutics is anticipated to see growth prospects during the forecast period as a result of firms' increasing focus on the development of revolutionary innovative therapies for effectively treating gastrointestinal ailments. During the forecast period, the growing development of gastrointestinal illness medications by regional and international vendors is anticipated to significantly contribute to the growth of the worldwide gastrointestinal disorders therapeutics market.
Gastroenterology Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to the analysis, the global gastroenterology market is currently led by countries in the North America region, due to the technological advancements, and an unprecedented change in lifestyle leading to a higher incidence of gastrointestinal diseases in this region. Along with this, the ulcerative colitis segment is projected to lead the market due to easy availability of medications to treat ulcerative colitis, over the forecast period.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 32.58 billion |
| Market size value in 2031 | USD 55.04 billion |
| Growth Rate | 6% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Gastroenterology Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Gastroenterology Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Gastroenterology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Gastroenterology Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Gastroenterology Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Gastroenterology Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
